Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabel Spriet

Showing results (41-50 of 237) with videos related to

Pageof 24
Sort By:
British Journal of Clinical Pharmacology|June 23, 2010
Increasing the dose of voriconazole compensates for enzyme induction by phenytoinIsabel Spriet, Philippe Meersseman, Wouter Meersseman, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2020
Comment on: Effectiveness and safety of an institutional aminoglycoside-based regimen as empirical treatment of patients with pyelonephritisIsabel Spriet, Reinier M van Hest, Willy E Peetermans, et al.
Emerging Infectious Diseases|August 26, 2010
Increasing incidence of mucormycosis in University Hospital, BelgiumVeroniek Saegeman, Johan Maertens, Wouter Meersseman, et al.
Pharmacy World & Science : PWS|November 18, 2006
Evaluation of drotrecogin alpha use in a Belgian university hospitalIsabel Spriet, Wouter Meersseman, Alexander Wilmer, et al.
Age and Ageing|September 30, 2020
Computerised prescribing support still needs a human touchCharlotte Quintens, Greet Van de Sijpe, Lorenz Van der Linden, et al.
Journal of Clinical Microbiology|January 1, 2016
Plasmalyte: No Longer a Culprit in Causing False-Positive Galactomannan Test ResultsIsabel Spriet, Katrien Lagrou, Johan Maertens, et al.
International Journal of Clinical Pharmacy|January 11, 2016
Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in BelgiumEline Vandael, Bert Vandenberk, Joris Vandenberghe, et al.
Expert Review of Anti-Infective Therapy|October 19, 2013
The Eagle-like effect of echinocandins: what's in a name?Kim Vanstraelen, Katrien Lagrou, Johan Maertens, et al.
International Journal of Clinical Pharmacy|March 11, 2017
Development of a risk score for QTc-prolongation: the RISQ-PATH studyEline Vandael, Bert Vandenberk, Joris Vandenberghe, et al.
British Journal of Clinical Pharmacology|December 3, 2020
Preventing medication-related harm: Perfect is the enemy of the goodGreet Van De Sijpe, Charlotte Quintens, Isabel Spriet, et al.
Pageof 24

Showing results (41-50 of 237) with videos related to

Sort By:
Pageof 24
British Journal of Clinical Pharmacology|June 23, 2010
Increasing the dose of voriconazole compensates for enzyme induction by phenytoinIsabel Spriet, Philippe Meersseman, Wouter Meersseman, et al.
The Journal of Antimicrobial Chemotherapy|September 3, 2020
Comment on: Effectiveness and safety of an institutional aminoglycoside-based regimen as empirical treatment of patients with pyelonephritisIsabel Spriet, Reinier M van Hest, Willy E Peetermans, et al.
Emerging Infectious Diseases|August 26, 2010
Increasing incidence of mucormycosis in University Hospital, BelgiumVeroniek Saegeman, Johan Maertens, Wouter Meersseman, et al.
Pharmacy World & Science : PWS|November 18, 2006
Evaluation of drotrecogin alpha use in a Belgian university hospitalIsabel Spriet, Wouter Meersseman, Alexander Wilmer, et al.
Age and Ageing|September 30, 2020
Computerised prescribing support still needs a human touchCharlotte Quintens, Greet Van de Sijpe, Lorenz Van der Linden, et al.
Journal of Clinical Microbiology|January 1, 2016
Plasmalyte: No Longer a Culprit in Causing False-Positive Galactomannan Test ResultsIsabel Spriet, Katrien Lagrou, Johan Maertens, et al.
International Journal of Clinical Pharmacy|January 11, 2016
Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in BelgiumEline Vandael, Bert Vandenberk, Joris Vandenberghe, et al.
Expert Review of Anti-Infective Therapy|October 19, 2013
The Eagle-like effect of echinocandins: what's in a name?Kim Vanstraelen, Katrien Lagrou, Johan Maertens, et al.
International Journal of Clinical Pharmacy|March 11, 2017
Development of a risk score for QTc-prolongation: the RISQ-PATH studyEline Vandael, Bert Vandenberk, Joris Vandenberghe, et al.
British Journal of Clinical Pharmacology|December 3, 2020
Preventing medication-related harm: Perfect is the enemy of the goodGreet Van De Sijpe, Charlotte Quintens, Isabel Spriet, et al.
Pageof 24